Durable SARS-CoV-2 antibodies bind to two viral targets at once A new study led by scientists at La Jolla Institute for Immunology (LJI) shows how ideal antibodies against SARS-CoV-2 hit their marks. Jan 17, 2023 0 64
Exposure to World Trade Center dust exacerbates cognitive impairment in an animal model of Alzheimer's Mice exposed to World Trade Center dust exhibit a significant impairment in spatial recognition and short- and long-term memory, as well as changes in genes related to immune-inflammatory responses and blood-brain barrier ... Jan 17, 2023 0 31
Academic and social justice leaders discuss health equity in communities of color A new Roundtable focusing on health equity in communities of color features the expertise and insights of five distinguished academic and social justice leaders. Moderated by Gail Christopher, DN, Executive Director of the ... Jan 17, 2023 0 3
Survey reveals physical and mental problems among Brazilian health workers during pandemic Poor physical and mental health was frequent among Brazilian health workers employed in the public sector during the COVID-19 pandemic, according to a study by researchers at the Federal University of São Carlos (UFSCar) ... Jan 17, 2023 0 1
Researchers reveal genetic predisposition to immunity against new variants of COVID-19 The SARS-CoV-2 delta variant that caused the third wave of COVID-19 in mid-2021 turned out to be more contagious than earlier SARS-CoV-2 variants. In addition, protein mutations in the delta variant were found to significantly ... Jan 17, 2023 0 43
Study shows marginalized communities benefit when states permit nurse practitioners to provide primary care Nurse practitioners from communities of color are generally underrepresented in the workforce. However, a recent study from West Virginia University occupational licensing experts revealed more appropriate racial representation ... Jan 17, 2023 0 47
New research shows pandemic's toll on frontline health care workers For frontline health care workers, the mental health impact from the pandemic is extending beyond career burnout. Much of the attention on the mental toll suffered by frontline workers has focused on post-traumatic stress ... Jan 17, 2023 0 5
Moderna reports positive results for RSV vaccine US biotech company Moderna on Tuesday announced positive interim trial results for its vaccine against respiratory syncytial virus (RSV) in adults over the age of 60. Jan 17, 2023 0 20
Pfizer to sell more drugs at cost to poor nations US pharmaceutical giant Pfizer announced on Tuesday that it will greatly expand the number of medicines and vaccines it sells on a not-for-profit basis to the world's poorest countries. Jan 17, 2023 0 3
National prostate cancer trial currently testing therapy based on molecular discovery A new prostate cancer therapy in clinical trials could treat patients resistant to treatment through targeting the disease on a molecular level, based on new Cleveland Clinic research. Jan 17, 2023 0 29
